Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

43.68
+0.33100.76%
Post-market: 43.730.0498+0.11%19:30 EDT
Volume:24.00K
Turnover:1.04M
Market Cap:211.41M
PE:- -
High:43.73
Open:43.54
Low:43.28
Close:43.35
52wk High:47.00
52wk Low:26.52
Shares:4.84M
Float Shares:4.84M
Volume Ratio:1.14
T/O Rate:0.50%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly : Berenberg Raises Target Price to $1220 from $1135

THOMSON REUTERS
·
Aug 13

Gamco Investors’ Mario Gabelli Ups Stake in Eli Lilly

TIPRANKS
·
Aug 13

Truist Financial Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Ads

MT Newswires Live
·
Aug 13

Health Care Roundup: Market Talk

Dow Jones
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

MaxCyte Q2 Revenue Beats Estimates

Reuters
·
Aug 13

Kura Oncology Q2 Product Revenue Rises 57% on Komzifti Uptake

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13

Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says

MT Newswires Live
·
Aug 12

Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 12

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

MT Newswires Live
·
Aug 12

Eli Lilly (LLY) Sues Six Companies Over Weight-Loss Drug Sales

TIPRANKS
·
Aug 12

Eli Lilly is Suing Pharmacies and Peptide Vendors over Sales of the Next Big Weight-Loss Drug: Retatrutide

Dow Jones
·
Aug 12

Amplifica Holdings Group: Closes Oversubscribed $26 Mln Series B Preferred Stock Financing Led by Tasso Partners, Participation from Eli Lilly & Co

THOMSON REUTERS
·
Aug 12

Cogent Biosciences, Inc. : Leerink Partners Cuts Target Price to $60 from $72

THOMSON REUTERS
·
Aug 12

Dow Jones Top Company Headlines at 9 am ET: Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs | Brinker ...

Dow Jones
·
Aug 12

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

GlobeNewswire
·
Aug 12

Legend Biotech Corp. : Oppenheimer Cuts to Perform from Outperform

THOMSON REUTERS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

TIPRANKS
·
Aug 12